ArticleNeuropsychopharmacology reports2023

Development and acceptability testing of a decision aid for considering whether to reduce antipsychotics in individuals with stable schizophrenia.

Yumi Aoki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.